AnalysisNews

SCTX today

$15.37-$0.99 (-6.05%)close Nov 16, 2026

Trend

DailyDowntrend (starting)

4 hourDescending Triangle

1 hourStrong Bearish

15 minSymmetric Triangle

5 minStrong Bearish

Daily trend turns up above $35.40

Key levels

Resistance$22.07

Resistance$18.30

Support$15.29

Latest news & SEC filings

AnalystHC Wainwright & Co. kept its Buy rating on SCTX.

All SCTX news →

Nasdaq · Healthcare

Scribe Therapeutics, Inc. (SCTX)

$15.37-0.99 (-6.05%)
WATCHLISTGrade: ARisk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
16.5317.6918.8520.0115.37Oct 14Oct 22Oct 30Nov 9
High17.25
Low15.28
Open16.53
Volume428K
Avg Vol360K
VWAP16.29
30d High21.17
30d Low15.37
30d Chg-5.88%

What Is the Price Target for SCTX?

SEPT Low Target

$37.00

SEPT Mid Target

$60.00

SEPT High Target

$60.00

Analyst Consensus

$60.00

Current: $16.49Upside: +264.0%Confidence: 85%Method: Analyst Consensus

Is SCTX a Buy or Sell Right Now?

83
Investability Score
WATCHLIST12-18 months
News summary · last 30 days
Nov 12▲ UpEarnings2 articles
Scribe Therapeutics reported a quarterly loss of $0.68 per share, which was smaller than analysts expected, though revenue of $1.600M fell short of forecasts. The company also filed a Form 8-K disclosing a major company event. Despite the revenue miss, the narrower-than-expected loss appears to have driven positive sentiment, with the stock closing at $16.99, up 3.79% on the day. The trading range was wide, from a low of $15.55 to a high of $17.49, indicating volatility around the news. The overall direction signal from today's news is bullish, primarily due to the earnings beat on the bottom line.

Thesis

    Test your own strategy on SCTX

    Describe your strategy in plain words, then scan, alert, backtest and paper trade it on SCTX with SEPT’s own market data.

    Start Free Trial →

    Is SCTX Overvalued or Undervalued?

    Valuation Verdict

    UNDERVALUED

    Methods Used

    Analyst Consensus

    Fair Value

    $60.00

    0

    Moat Score

    NONE

    0/9

    Piotroski Score

    N/A

    Altman Z-Score

    What Is Smart Money Doing with SCTX?

    Insider Signal

    NEUTRAL

    0 buys / 0 sells (90d)

    Congress Signal

    NEUTRAL

    0 buys / 0 sells (90d)

    Institutional

    N/A

    Short Squeeze Risk

    MEDIUM

    Signal: NEUTRAL

    Track Smart Money Across 4,000+ Stocks

    Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

    See Smart Money Data →

    SCTX Growth Story

    Revenue YoY

    N/A%

    3yr Revenue CAGR

    N/A%

    EPS Growth YoY

    N/A

    FCF Growth YoY

    N/A%

    Revenue Trend

    UNKNOWN

    Dark Pool Trades for SCTX

    PREVIEW

    Recent off-exchange (dark pool) prints for SCTX: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.

    TimePriceSizeValueSide
    20:37:05$15.611,167$$18KMIDPOINT
    20:05:04$16.061,001$$16KSELL
    18:32:44$16.473,000$$49KBUY
    18:32:31$16.342,910$$48KSELL
    18:32:31$16.1810,500$$170KSELL

    5 dark pool trades shown · $$301K preview volume

    Real-time institutional flow, block trades, and net positioning

    See all dark pool activity

    Full AI Research Report

    SEPT's Trading AI has generated a free, downloadable PDF research report for Scribe Therapeutics, Inc. (SCTX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

    Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

    Your strategy, tested before real money.

    Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.

    Try SEPT Free for 7 Days →

    SCTX — frequently asked questions

    What is SCTX stock price today?

    Scribe Therapeutics, Inc. (SCTX) is at $15.37, down 6.05% (-$0.99) at the Nov 16, 2026 close.

    Why is SCTX stock moving today?

    Latest SCTX news — Sep 3, 2026: HC Wainwright & Co. kept its Buy rating on SCTX.

    Why did SCTX stock move on Nov 12, 2026?

    Scribe Therapeutics reported a quarterly loss of $0.68 per share, which was smaller than analysts expected, though revenue of $1.600M fell short of forecasts. The company also filed a Form 8-K disclosing a major company event.

    What is the SCTX price target?

    The average analyst price target for SCTX is $60.00, ranging from $37 to $60, based on 6 analysts.

    What do analysts rate SCTX?

    Analyst ratings for SCTX: 0 Buy, 6 Hold, 0 Sell — consensus Hold.

    Did SCTX beat earnings?

    SCTX last reported on Sep 2, 2026: EPS -$2.62 vs -$3.62 expected — a beat of 27.6%.

    What are SCTX support and resistance levels?

    Support: $15.29. Resistance: $18.30, $22.07, $27.20.

    What are insiders doing with SCTX?

    Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

    What is the latest news on SCTX?

    Sep 3, 2026: HC Wainwright & Co. kept its Buy rating on SCTX.